Balancing Container Closure Integrity and Aesthetics for a Robust Aseptic or Sterile Vial Packaging System

References

1. 1.↵
   1. Hamada M.

   The Industry's Shift to 100% Non-Destructive Container Closure Integrity Testing with USP <1207>. Biosimilar Development [Online] 2016. https://www.biosimilardevelopment.com/doc/the-industry-s-shift-to-non-destructive-container-closure-integrity-testing-with-usp-0001 (accessed May 18, 2018).

   Google Scholar
2. 2.↵
   1. Ovadia R.,
   2. Streubel A.,
   3. Webb-Vargus Y.,
   4. Ulland L.,
   5. Luemkemann J.,
   6. Rauch K.,
   7. Eder J.,
   8. Lam P.,
   9. Pegoulia V.,
   10. Maa Y.-F.

   Quantifying the Vial Capping Process: Residual Seal Force and Container Closure Integrity. PDA J. Pharm. Sci. Technol. 2019, 73 (1), 2–15.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
3. 3.↵
   1. Morton D. K.

   Container/Closure Integrity of Parenteral Vials. J. Parenter. Sci. Technol. 1987, 41 (5), 145–158.

   OpenUrlPubMedGoogle Scholar
4. 4.↵
   1. Mathaes R.,
   2. Mahler H.-C.,
   3. Roggo Y.,
   4. Huwyler J.,
   5. Eder J.,
   6. Fritsch K.,
   7. Posset T.,
   8. Mohl S.,
   9. Streubel A.

   Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity (CCI) in GMP Drug Product Manufacturing. PDA J. Pharm. Sci. Technol. 2016, 70 (2), 109–119.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
5. 5.↵
   1. Mathaes R.,
   2. Mahler H.-C.,
   3. Buettiker J.-P.,
   4. Roehl H.,
   5. Lam P.,
   6. Brown H.,
   7. Luemkemann J.,
   8. Adler M.,
   9. Huwyler J.,
   10. Streubel A.,
   11. Mohl S.

   The Pharmaceutical Vial Capping Process: Container Closure Systems, Capping Equipment, Regulatory Framework, and Seal Quality Tests. Eur. J. Pharm. Biopharm. 2016, 99, 54–64.

   OpenUrlPubMedGoogle Scholar
6. 6.↵
   1. Mathaes R.,
   2. Mahler H.-C.,
   3. Roggo Y.,
   4. Ovadia R.,
   5. Lam P.,
   6. Stauch O.,
   7. Vogt M.,
   8. Roehl H.,
   9. Huwyler J.,
   10. Mohl S.,
   11. Streubel A.

   Impact of Vial Capping on Residual Seal Force and Container Closure Integrity. PDA J. Pharm. Sci. Technol. 2016, 70 (1), 12–29.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
7. 7.↵
   1. Morton D. K.,
   2. Lordi N. G.

   Residual Seal Force Measurement of Parenteral Vials. II. Elastomer Evaluation. PDA J. Pharm. Sci. Technol 1988, 42 (2), 57–61.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
8. 8.↵
   1. Ludwig J. D.,
   2. Davis C. W.

   Automated Method for Determining Instron Residual Seal Force of Glass Vial/Rubber Closure Systems Part II. 13 mm Vials. PDA J. Pharm. Sci. Technol. 1995, 49 (5), 253–256.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
9. 9.↵
   1. Ludwig J. D.,
   2. Nolan P. D.,
   3. Davis C. W.

   Automated Method for Determining Instron Residual Seal Force of Glass Vial/Rubber Closure Systems. PDA J. Pharm. Sci. Technol. 1993, 47 (5), 211–253.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
10. 10.↵
    1. Morton D. K.,
    2. Lordi N. G.

    Residual Seal Force Measurements of Parenteral Vials. II. Elastomer Evaluation. J Parenter. Sc.i Technol. 1988, 42 (2), 57–61.

    OpenUrlPubMedGoogle Scholar
11. 11.↵
    1. Mathaes R.,
    2. Mahler H.-C.,
    3. Vorgrimler L.,
    4. Steinberg H.,
    5. Dreher S.,
    6. Roggo Y.,
    7. Nieto A.,
    8. Brown H.,
    9. Roehl H.,
    10. Adler M.,
    11. Luemkemann J.,
    12. Huwyler J.,
    13. Lam P.,
    14. Stauch O.,
    15. Mohl S.,
    16. Streubel A.

    The Pharmaceutical Capping Process–Correlation between Residual Seal Force, Torque Moment, and Flip-off Removal Force. PDA J. Pharm. Sci. Technol. 2016, 70 (3), 218–229.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
12. 12.↵
    1. Zeng Q.,
    2. Zhao X.

    Time-Dependent Testing Evaluation and Modeling of Rubber Stopper Seal Performance. PDA J. Pharm. Sci. Technol. 2018, 72 (2), 134–148.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
13. 13.↵
    1. DeGrazio F. L.

    Holistic Considerations in Optimizing a Sterile Product Package to Ensure Container Closure Integrity. PDA J. Pharm. Sci. Technol. 2018, 72 (1), 15–34.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
14. 14.↵
    1. Orosz S.,
    2. Guazzo D.

    Glass Vial Finish Defects: Leak Detection and Product Risk Assessment. Parenteral Drug Association Annual Meeting, Orlando, FL, 2010.

    Google Scholar
15. 15.↵
    1. Lam P.,
    2. Stern A.

    Visualization Techniques for Assessing Design Factors That Affect the Interaction between Pharmaceutical Vials and Stoppers. PDA J. Pharm. Sci. Technol. 2010, 64 (2), 182–187.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
16. 16.↵
    1. Davidson K.,
    2. Mangus J.

    Selecting and Verifying Integral Packaging Systems for Injectable Drug Products. Poster Presentation, West Pharmaceutical Services, Inc.; 9029.

    Google Scholar
17. 17.↵
    1. D'Ambrisi T.,
    2. Johns J.

    Container Closure Integrity as a Function of Residual Seal Force. BMS Internal Document, DCN 950059953. New Brunswick, New Jersey, 2014.

    Google Scholar
18. 18.↵
    1. Kirsch L.,
    2. Nguyen L.,
    3. Moeckly C.,
    4. Gerth R

    . Pharmaceutical Container/Closure Integrity II: The Relationship between Microbial Ingress and Helium Leak Rates in Rubber-Stoppered Glass Vials. PDA J. Pharm. Sci. Technol. 1997, 51 (5), 195–202.

    OpenUrlAbstract/FREE Full TextGoogle Scholar